Table 1. Effects of kallistatin on serum AST, ALT and Albumin in CCl₄-induced liver fibrosis rats (n = 8).

Treatment	AST(U/L)	ALT(U/L)	Albumin(g/L)
negative control	78.99±2.63	66.29±5.29	45.50±3.20
CCl4	177.43±4.11##	140.77±15.27##	25.3±2.50##
CCl4+kallistatin (0.125 mg/kg)	114.07±5.88**	102.86±17.04**	29.38±2.10*
CCl4+kallistatin (0.5 mg/kg)	101.25±4.53**	92.65±10.25**	35.68±4.35**
CCl4+kallistatin (2 mg/kg)	85.77±3.51**	81.23±5.99**	42.51±3.090**

The results are showed as mean±SD.

^## p<0.01 vs. negative control;

*p<0.05 vs. model control;

**p<0.01 vs. model control.